KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) EPS (Basic) (2017 - 2025)

Guardant Health's EPS (Basic) history spans 9 years, with the latest figure at -$1.0 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 11.11% year-over-year to -$1.0; the TTM value through Dec 2025 reached -$3.32, up 6.74%, while the annual FY2025 figure was -$3.32, 6.74% up from the prior year.
  • EPS (Basic) for Q4 2025 was -$1.0 at Guardant Health, down from -$0.75 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.65 in Q2 2023 and bottomed at -$2.25 in Q2 2022.
  • The 5-year median for EPS (Basic) is -$0.95 (2021), against an average of -$1.08.
  • The largest annual shift saw EPS (Basic) crashed 275.86% in 2021 before it skyrocketed 71.11% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at -$0.89 in 2021, then tumbled by 53.93% to -$1.37 in 2022, then fell by 18.25% to -$1.62 in 2023, then surged by 44.44% to -$0.9 in 2024, then dropped by 11.11% to -$1.0 in 2025.
  • Per Business Quant, the three most recent readings for GH's EPS (Basic) are -$1.0 (Q4 2025), -$0.75 (Q3 2025), and -$0.8 (Q2 2025).